Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 15
Submit an article Journal homepage
252
Views
4
CrossRef citations to date
0
Altmetric
Review

Azole resistance in Aspergillus species: promising therapeutic options

Shirisha Pasulaa Department of Internal medicine, Division of Infectious diseases, Detroit Medical Center/Wayne State University, Detroit, MI, USAORCID Iconhttps://orcid.org/0000-0001-8930-944XView further author information
ORCID Icon &
Pranatharthi H. Chandrasekarb Department of Internal Medicine, Division of Infectious diseases, Wayne State University, Detroit, MI, USACorrespondence[email protected]
View further author information
Pages 2071-2078 | Received 27 Jan 2021, Accepted 04 Jun 2021, Published online: 21 Jun 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Geetha Sivasubramanian & Pranatharthi H Chandrasekar. (2022) Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature. Expert Opinion on Pharmacotherapy 23:5, pages 543-549.
Read now

Articles from other publishers (3)

Davide Bosetti & Dionysios Neofytos. (2023) Invasive Aspergillosis and the Impact of Azole-resistance. Current Fungal Infection Reports 17:2, pages 77-86.
Crossref
Pilar Escribano, Ana Gómez, Elena Reigadas, Patricia Muñoz & Jesús Guinea. (2022) EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings. Antimicrobial Agents and Chemotherapy 66:9.
Crossref
Qian Zhang, Fangyan Liu, Meng Zeng, Jinping Zhang, Yanfei Liu, Caiyan Xin, Yingyu Mao & Zhangyong Song. (2022) Antifungal Activity of Sodium New Houttuyfonate Against Aspergillus fumigatus in vitro and in vivo. Frontiers in Microbiology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.